(Q35667018)

9 August 2017

1 reference

title

Drug resistance in non-subtype B HIV-1. (English)

1 reference

9 August 2017

Rami Kantor

1

1 reference

9 August 2017

David Katzenstein

series ordinal

2

1 reference

9 August 2017

publication date

1 March 2004

1 reference

Journal of Clinical Virology

9 August 2017

published in

1 reference

9 August 2017

volume

29

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

152-159

1 reference

Recombinant strains of HIV type 1 in the United Kingdom

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

High Frequency of Non-B Subtypes in Newly Diagnosed HIV-1 Infections in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Isolation of a new human retrovirus from West African patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

HIV-1 subtypes in Luxembourg, 1983-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Molecular screening for HIV-1 group N and simian immunodeficiency virus cpz-like virus infections in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

AIDS as a zoonosis: scientific and public health implications

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Resistance to antiretroviral agents in individuals with HIV-1 non-B subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: a sentinel site for monitoring HIV genetic diversity in North America. Centers for Disease Control and Prevention-Bronx Leban

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Group O human immunodeficiency virus-1 infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Interpatient genetic variability of HIV-1 group O

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Timing the ancestor of the HIV-1 pandemic strains

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase n

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

International perspectives on antiretroviral resistance. Resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

HIV-1 group O virus infection in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Estimated Global Distribution and Regional Spread of HIV-1 Genetic Subtypes in the Year 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

The genetic variability of HIV-1 and its implications

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse transcriptase and protease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Human immunodeficiency virus type 2

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Recombination in AIDS viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Recombination in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

HIV-1 nomenclature proposal

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Genotypic resistance mutations to antiretroviral drugs in HIV-1 B and non-B subtypes from Cuba

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Genotypic testing for human immunodeficiency virus type 1 drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2803%2900115-X

7 January 2021

10.1016/S1386-6532(03)00115-X

Identifiers

DOI

1 reference

9 August 2017

1 reference